2g8e
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2g8e.gif|left|200px]] | [[Image:2g8e.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2g8e", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | | | + | --> |
| - | | | + | {{STRUCTURE_2g8e| PDB=2g8e | SCENE= }} |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Calpain 1 proteolytic core in complex with SNJ-1715, a cyclic hemiacetal-type inhibitor''' | '''Calpain 1 proteolytic core in complex with SNJ-1715, a cyclic hemiacetal-type inhibitor''' | ||
| Line 30: | Line 27: | ||
[[Category: Davies, P L.]] | [[Category: Davies, P L.]] | ||
[[Category: Moldoveanu, T.]] | [[Category: Moldoveanu, T.]] | ||
| - | [[Category: | + | [[Category: Aldehyde]] |
| - | [[Category: | + | [[Category: Cyclic hemiacetal]] |
| - | [[Category: | + | [[Category: Inhibitor]] |
| - | [[Category: | + | [[Category: Peptidase]] |
| - | [[Category: | + | [[Category: Protease]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:48:57 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 01:48, 4 May 2008
Calpain 1 proteolytic core in complex with SNJ-1715, a cyclic hemiacetal-type inhibitor
Overview
Calpains are intracellular calcium-activated cysteine proteases whose unregulated proteolysis following the loss of calcium homeostasis can lead to acute degeneration during ischemic episodes and trauma, as well as Alzheimer's disease and cataract formation. The determination of the crystal structure of the proteolytic core of mu-calpain (muI-II) in a calcium-bound active conformation has made structure-guided design of active site inhibitors feasible. We present here high-resolution crystal structures of rat muI-II complexed with two reversible calpain-specific inhibitors employing cyclic hemiacetal (SNJ-1715) and alpha-ketoamide (SNJ-1945) chemistries that reveal new details about the interactions of inhibitors with this enzyme. The SNJ-1715 complex confirms that the free aldehyde is the reactive species of the cornea-permeable cyclic hemiacetal. The alpha-ketoamide warhead of SNJ-1945 binds with the hydroxyl group of the tetrahedral adduct pointing toward the catalytic histidine rather than the oxyanion hole. The muI-II-SNJ-1945 complex shows residue Glu261 displaced from the S1' site by the inhibitor, resulting in an extended "open" conformation of the domain II gating loop and an unobstructed S1' site. This conformation offers an additional template for structure-based drug design extending to the primed subsites. An important role for the highly conserved Glu261 is proposed.
About this Structure
2G8E is a Single protein structure of sequence from Rattus norvegicus. Full crystallographic information is available from OCA.
Reference
Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography., Cuerrier D, Moldoveanu T, Inoue J, Davies PL, Campbell RL, Biochemistry. 2006 Jun 20;45(24):7446-52. PMID:16768440 Page seeded by OCA on Sun May 4 04:48:57 2008
